Document Detail

Long-term results in the treatment of vitiligo with oral khellin plus UVA.
MedLine Citation:
PMID:  11358729     Owner:  NLM     Status:  MEDLINE    
This study was performed to assess the effectiveness and short-term and long-term safety of oral khellin plus UVA (KUVA) in patients with vitiligo. Twenty-eight patients (13 males and 15 females; mean age, 34 years; [age range, 15-51 years]) most with extensive generalized vitiligo of more than 6 months duration had received KUVA at sometime during a 14-year period. The response to treatment (i.e. repigmentation of depigmented areas) was rated retrospectively comparing photographs taken before and after therapy and correlation analysis revealed that it was statistically significantly linked to the number of KUVA treatments (r = 0.833, P = 0.001) and to total cumulative UVA dose (r = 0.840, P = 0.001). Of 17 patients who had continued therapy for longer than 3 months, 7 (41%) had a good response (i.e., more than 70% repigmentation of lesional skin) after a mean of 194 treatments (range, 69-386 treatments) and a mean cumulative UVA dose of 2,036 J/cm2 (range, 690-4,411 J/cm2), whereas lower response grades were observed in the patients with lower treatment numbers. The most common short-term side effect was mild nausea, occurring in 8 of 28 patients (29%), and mainly in the first week(s) of treatment. Follow-up assessment at a mean of 40 months (range, 4-110 months) after the end of KUVA therapy available in 23 of 28 patients revealed no skin cancers or actinic skin damage in any patient. These data indicate that KUVA seems to be safe as well as effective for vitiligo, provided treatment is administered long enough.
A Hofer; H Kerl; P Wolf
Related Documents :
10535249 - Twice weekly 5 mg dexamethasone oral pulse in the treatment of extensive alopecia areata.
15034819 - Laser hair removal.
9812029 - Puva treatment for alopecia areata. experience in a turkish population.
6183879 - The effect of etretinate on fibronectin in psoriatic skin.
2426909 - Topical immunotherapy of alopecia areata. a follow-up study.
20883409 - Could azathioprine be considered as a therapeutic alternative in the treatment of alope...
8758169 - A comparison of epidural infusions of fentanyl or pethidine with bupivacaine in the man...
19171279 - Arthroscopic biceps augmentation for avoiding undue tension in repair of massive rotato...
10932659 - Fissurectomy as a treatment for anal fissures in children.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  European journal of dermatology : EJD     Volume:  11     ISSN:  1167-1122     ISO Abbreviation:  Eur J Dermatol     Publication Date:    2001 May-Jun
Date Detail:
Created Date:  2001-05-18     Completed Date:  2001-07-12     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  9206420     Medline TA:  Eur J Dermatol     Country:  France    
Other Details:
Languages:  eng     Pagination:  225-9     Citation Subset:  IM    
Department of Dermatology, University of Graz, Auenbruggerplatz 8, A-8036, Graz, Austria.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Khellin / adverse effects,  therapeutic use*
Middle Aged
Photochemotherapy / adverse effects,  methods*,  standards
Retrospective Studies
Severity of Illness Index
Time Factors
Treatment Outcome
Ultraviolet Therapy / adverse effects,  methods*,  standards
Vitiligo / classification,  drug therapy*,  pathology,  radiotherapy*
Reg. No./Substance:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  The safety of calcitriol 3 microg/g ointment. Evaluation of cutaneous contact sensitization, cumulat...
Next Document:  Bullous pemphigoid in a leg affected with hemiparesia: a possible relation of neurological diseases ...